First Time Loading...

Kazia Therapeutics Ltd
ASX:KZA

Watchlist Manager
Kazia Therapeutics Ltd Logo
Kazia Therapeutics Ltd
ASX:KZA
Watchlist
Price: 0.08 AUD Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

KZA Price Targets Summary
Kazia Therapeutics Ltd

Wall Street analysts forecast KZA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KZA is 0.3 AUD .

Lowest
Price Target
Not Available
Average
Price Target
0.3 AUD
275% Upside
Highest
Price Target
Not Available
Kazia Therapeutics Ltd Competitors:
Price Targets
IGMS
IGM Biosciences Inc
130% Upside
300685
Amoy Diagnostics Co Ltd
30% Upside
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
103% Upside
251120
Bio-FD&C Co Ltd
35% Upside
ZYME
Zymeworks Inc
66% Upside
BCYC
Bicycle Therapeutics PLC
78% Upside
DSGN
Design Therapeutics Inc
33% Upside
300142
Walvax Biotechnology Co Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
Kazia Therapeutics Ltd

For the last 8 years the compound annual growth rate for Kazia Therapeutics Ltd's revenue is -16%. The projected CAGR for the next 2 years is 2 428%.

-16%
Past Growth
2 428%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Kazia Therapeutics Ltd

Operating Income forecast
is not available for
Kazia Therapeutics Ltd

Net Income
Forecast

Net Income Estimate
Kazia Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KZA's stock price target?
Price Target
0.3 AUD

According to Wall Street analysts, the average 1-year price target for KZA is 0.3 AUD .

What is Kazia Therapeutics Ltd's Revenue forecast?
Projected CAGR
2 428%

For the last 8 years the compound annual growth rate for Kazia Therapeutics Ltd's revenue is -16%. The projected CAGR for the next 2 years is 2 428%.